Adverse cerebral outcomes have been described in most perioperative settings; however, for quite some time, cardiac surgery has been the poster child for cognitive dysfunction as well as incrementally severe complications, such as delirium, encephalopathy and stroke. Not that these complications do not occur in other operative settings, but with the incidence of post-cardiac surgery complications being generally higher than in other settings, cardiac surgery patients are an easily identifiable group to study in detail. Understanding the factors that influence perioperative cerebral outcome has never been more relevant, as not only are patients presenting for surgery at an increasingly older age (i.e., consistent with global demographic changes) but they frequently have multiple co-morbidities (many of which are risk factors for neurologic injury). Despite changes in the management of coronary artery disease (CAD) that have lead to a gradual decline in these procedures over the past 5–10 years, coronary artery bypass graft surgery (CABG) remains one of the most commonly performed operations. Furthermore, a recent large-scale study identified that the optimal management of multivessel CAD was with CABG, as opposed to percutaneous intervention. This may lead to a resurgence of CABG surgery with a further increase in the overall number of patients manifesting neurologic dysfunction. Much has been written about the risk factors for adverse neurologic outcome. Although many factors are modifiable, such as the way to approach ascending aortic atheromatous disease, many are not, which is clearly the case regarding one’s genetic composition. Several recent trials have highlighted how our genetic milieu either increases the predisposition for neurologic injury or impairs the ability to recover once that injury has occurred. Despite pointing to identifiable yet sometimes divergent genetic risk factors, each of these studies has distinct strengths and weaknesses. However, regardless of reports of significant findings that provide provocative scientific insights, the study and understanding of perioperative genomics is in its relative infancy. Indeed, there are several thematic deficiencies present in most of the reported studies. The first and foremost shortcoming relates to the relatively small size of most trials. Although some of the trials are larger than the majority of other perioperative clinical trials, they are smaller than needed to avoid the problems of poor statistical power, multiple comparisons, and the seemingly ever-changing bioinformatics field. However, advancements in analytical techniques with expanded capability and accuracy have facilitated gathering the needed genetic information in a more cost-effective manner, making it possible to study larger populations. The incredible complexity of our genetic code presents an expanding challenge to our ability to fully understand the effects of genetic variation. Variations in genetic make-up have been described by the concept of single nucleotide polymorphisms (SNPs), where individual nucleotides (i.e., base pairs) differ within specific genes, thus producing various alleles. The limitations of analytical techniques have restricted the number of SNPs that can reasonably be interrogated. It has also led us to examine specific and pre-determined, though biologically plausible, targets. However, these a priori defined SNPs may completely miss the more important and as yet unknown variants. As a result, whole-genotype analysis, although suffering its own set of limitations, has improved the H. P. Grocott, MD (&) Departments of Anesthesia and Surgery, University of Manitoba, CR3008-369 Tache Avenue, Winnipeg, MB R2H 2A6, Canada e-mail: hgrocott@sbgh.mb.ca
Read full abstract